3,4-Azocinedicarboxylicacid, 1,6,7,8-tetrahydro-, 3,4-dimethyl ester (62563-00-2)

Identification
Name:	3,4-Azocinedicarboxylicacid, 1,6,7,8-tetrahydro-, 3,4-dimethyl ester
Synonyms:	3,4-Azocinedicarboxylicacid, 1,6,7,8-tetrahydro-, dimethyl ester (9CI); NSC 275382
CAS:	62563-00-2
Molecular Formula:	C11H15 N O4
Molecular Weight:	225.2411
InChI:	InChI=1/C11H15NO4/c1-15-10(13)8-5-3-4-6-12-7-9(8)11(14)16-2/h5,7,12H,3-4,6H2,1-2H3/b8-5+,9-7+
Molecular Structure:
Properties
Flash Point:	153.4°C
Boiling Point:	330°C at 760 mmHg
Density:	1.15g/cm³
Refractive index:	1.491
Flash Point:	153.4°C
Safety Data

Other Product

3,4-Azocinedicarboxylicacid, 1-[2-[4-(bromomethyl)-1,3-dioxolan-2-yl]ethyl]-1,6,7,8-tetrahydro-,3,4-dimethyl ester
3,4-Azocinedicarboxylicacid, 1,6,7,8-tetrahydro-1-(2-phenylethyl)-, 3,4-dimethyl ester
Butanoic acid, 2,2-dimethyl-,decahydro-3-(cyclopentylsulfonyl)-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester
Butanoic acid, 2,2-dimethyl-,3-[(fluoromethyl)sulfinyl]decahydro-7-methyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester
Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro- 4-hydroxy- 6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha-(R*),3-alpha,7-beta, 8-beta-(2S*,4S*),8a-beta))-
Isoquinolinium,1,2,3,4-tetrahydro-8-hydroxy- 1-[(3-hydroxy-4-methoxyphenyl)methyl]-7- methoxy-2,2-dimethyl-,(1R)-
Spiro[3-cyclohexene-1,4'(3'H)-[1H-7,9a]methanocyclohepta[c]pyran]-1',2,9'(4'aH)-trione,5',6',7',8'-tetrahydro-6-(hydroxymethyl)-5,5-dimethyl-8'-methylene-,(1S,4'aS,6R,7'R,9'aS)- (9CI)
1H-3-Benzazepin-7-ol,6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-8-methoxy-
Spiro[cyclohexane-1,2'(1'H)-quinazolin]-4'(3'H)-one,5',6',7',8'-tetrahydro-
5',8a'-dimethyl-3',4',8',8a'-tetrahydro-2'H-spiro[1,3-dioxolane-2,1'-naphthalen]-6'(7'H)-one
Spiro[cyclohexane-1,2'-[2H]inden]-3-one,4',5',6',7'-tetrahydro-1',3'-dimethyl-
Propanoic acid, 2,2-dimethyl-,8-[3-(4-chlorophenyl)-5-methyl-1H-pyrazol-1-yl]-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl ester
2H-Pyran-3-carboxylic acid,2-[2-(acetyloxy)-8-[[10-(acetyloxy)-7- hydroxy-5,9-dimethyl-1-(1-methyl-3-oxo- 1-butenyl)-6-oxo-6H-naphtho[2,1-d][1,3]- dioxin-8-yl]amino]-1,3,7-trimethyl-8-oxo-4,- 6-octadienyl]tetrahydro-4,6-dihydroxy-5- methyl-,methyl ester
2H-Pyran-3-carboxylic acid,4-(acetyloxy)-2-[8-[[10-(acetyloxy)-7- hydroxy-5,9-dimethyl-1-(1-methyl-3-oxo- 1-butenyl)-6-oxo-6H-naphtho[2,1-d][1,3]- dioxin-8-yl]amino]-2-hydroxy-1,3,7- trimethyl-8-oxo-4,6-octadienyl]tetrahydro-6- hydroxy-5-methyl-,methyl ester
2H-Pyran-3-carboxylic acid,4-(acetyloxy)-2-[8-[[10-(acetyloxy)-7- hydroxy-5,9-dimethyl-1-(1-methyl-3-oxo- 1-butenyl)-6-oxo-6H-naphtho[2,1-d][1,3]- dioxin-8-yl]amino]-2,3-dihydroxy-1,3,7- trimethyl-8-oxo-4,6-octadienyl]tetrahydro-6- hydroxy-5-methyl-,methyl ester
[1,2'-Bianthracene]-9,9',10,10'-tetrone,5',6',7',8'-tetrahydro-1',2,5',6',7',8,8'-heptahydroxy-3',6-dimethoxy-3,6'-dimethyl-,(5'R,6'S,7'R,8'S)- (9CI)
Isoquinolinium,1,2,3,4-tetrahydro-7-hydroxy-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2,2-dimethyl-,(1S)-
1H-2-Benzopyran-8-carboxylic acid,3,4,4a,7-tetrahydro-1-oxo-6-(3-oxobutyl)-, methyl ester
2-methyl-butyric acid 8-{2-[4-(tert-butyl-dimethyl-silanyloxy)-6-oxo-tetrahydro-pyran-2-yl]-ethyl}-7-methyl-6-oxo-1,2,6,7,8,8a-hexahydro-naphthalen-1-yl ester
Benz[c]acridin-8(9H)-one,7,10,11,12-tetrahydro-7-[3-methoxy-4-(1-oxopropoxy)phenyl]-10,10-dimethyl-